Trials of influenza a/new jersey /76 virus vaccine in normal children: An overview of age-related antigenicity and reactogenicity

Journal of Infectious Diseases

Volumn 136, Issue , 1977, Pages S731-S741

  Wright, Peter F ^a   Thompson, Juliette ^a   Vaughn, William K ^a   Folland, David S ^a   Sell, Sarah H W ^a   Karzon, David T ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; VIRUS ANTIBODY;

ADOLESCENT; AGE; BLOOD; BLOOD AND HEMOPOIETIC SYSTEM; CHILD; COMPUTER; COMPUTER ANALYSIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ADMINISTRATION; DRUG ANALYSIS; DRUG COMPARISON; DRUG DOSE; DRUG RESPONSE; DRUG TOLERANCE; FEVER; HUMAN; HUMAN CELL; IMMUNIZATION; INFANT; INFLUENZA VIRUS; NORMAL HUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SWINE INFLUENZA VIRUS; VACCINATION;

ADOLESCENT; AGING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEVER; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INFLUENZA A VIRUS; INFLUENZA VACCINES;

EID: 0017610114     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/136.Supplement_3.S731     Document Type: Article

References (11)

1. Report of the Committee on Infectious Diseases. 17th ed. American Academy of Pediatrics, Evanston, Ill., 1974, p. 139.
2. Marine, W. M., Stuart-Harris, C. Reaction and sero logic response in young children and infants after administration of inactivated monovalent influenza A vaccine. J. Pediatr. 88:26-30, 1976.
3. Wright, P. F., Sell, S. H., Thompson, J., Karzon, D. K. Clinical reaction and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. J. Pediatr. 88:31-35, 1976.
4. Lerman, S. J. Reactivity and immunogenicity of mono valent A/New Jersey/76 influenza virus vaccines in children. J. Infect. Dis. l36(Suppl.):S563-S570, 1977.
5. Center for Disease Control. Recommendations of the Committee on Infectious Diseases of the American Academy of Pediatrics: immunization of children at high risk from influenza infection. Morbidity and Mortality Weekly Rep. 25 (36):285, 1976.
6. Center for Disease Control. Recommendations of the Public Health Service Advisory Committee on Immunization Practices: influenza vaccine—second supplemental statement. Morbidity and Mortality Weekly Rep. 25 (35):357-359, 1976.
7. Center for Disease Control. Guillain-Barre syndrome- United States. Morbidity and Mortality Weekly Rep. 25 (50):401, 1976.
8. Atkins, E., Bodel, P. Fever In B. W. Zweifach, L. Grant, and R. T. McCluskey [ed.]. The inflammatory process. Vol. 3. Academic Press, New York, 1974, p. 478.
9. Boyer, K. M., Cherry, J. D., Wright, P. F., Lerman, S. J., Gross, P. A., Foy, H. M., Taylor, J. W., Noble, G. R. Clinical reactions and serologic responses in healthy children aged six to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccines. J. Infect. Dis. 136(Suppl.): S579-S583, 1977.
10. Gross, P. Reactogenicity and immunogenicity of bi valent influenza vaccine in one-and two-dose trials in children. J. Infect. Dis. 136(Suppl.):S616-S625, 1977.
11. Ennis, F. A., Mayner, R. E, Barry, D. W., Manischewitz, J. E., Dunlop, R. C., Verbonitz, M. W., Bozeman, F. M., Schild, G. C. Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines. J. Infect. Dis. 136(Suppl.):S397-S406, 1977.